Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Bone problems news

Show

From To
ART: Daily Vitamin D and Calcium Stave Off Bone Loss

Patients with HIV infection who take antiretroviral therapy (ART) can also reduce antiretroviral therapy-related bone loss by 50% by taking daily high-dose vitamin D and calcium supplements, according to a 48-week study.

Published
17 June 2015
From
Medscape
Truvada PrEP causes only mild loss of bone mineral density

Treatment with tenofovir/emtricitabine (Truvada) as pre-exposure prophylaxis (PrEP) is associated with small but significant decreases in bone mineral density (BMD), investigators from the landmark iPrEx study report in the

Published
14 May 2015
By
Michael Carter
FRAX fracture prediction tool underestimates fracture risk in people with HIV

The Fracture Risk Assessment Tool (FRAX), an online tool developed by the World Health Organization and used to help guide decisions about who to screen or treat

Published
18 March 2015
By
Theo Smart
Screening for bone fracture risk should be routine for over-40s with HIV, new guidelines recommend

Screening for fracture risk should be a routine part of HIV care for all over-40s, and all postmenopausal women, all men over 50 and people at

Published
02 February 2015
By
Keith Alcorn
The puzzle of thin bones in young MSM

In Amsterdam, researchers have established a large cohort, called AGEhIV, of both HIV-positive and HIV-negative people of similar age and risk behaviours. Young MSM in this study, regardless of HIV infection, were surprisingly at risk for having thinner-than-normal bones.

Published
01 October 2014
From
CATIE
Gilead Sciences: A Preview of Important HIV Drug Study Results

Gilead is running nine phase III studies involving tenofovir alafenamide (TAF), which reflects the importance of the drug to Gilead's future HIV business. It is collecting an enormous amount of clinical data in which to make the case that TAF should be a preferred backbone drug for new and existing HIV patients, as well as patients who cannot use Viread because of pre-existing kidney conditions.

Published
23 September 2014
From
The Street
HIV/HCV co-infection associated with increased risk of osteoporosis and fractures

Co-infection with HIV and hepatitis C virus (HCV) is associated with increased risks of low bone mineral density (BMD) and fracture, investigators report in the

Published
08 July 2014
By
Michael Carter
CROI 2014: Researchers discuss HIV, aging, and frailty

People living with HIV are at greater risk of geriatric syndromes such as frailty and difficulty with daily activities than HIV negative people of the same age -- and this can have a significant effect upon their quality of life as they age, according to several studies presented at the 14th Conference on Retroviruses and Opportunistic Infections (CROI 2014) last month in Boston.

Published
08 April 2014
From
HIVandHepatitis.com
HIV Drug Linked to Low Bone Density in Babies

In a cohort study, babies of mothers taking tenofovir (Viread) had an average whole-body bone mineral content about 8 grams less than babies whose mothers did not use the drug, according to George Siberry, MD, of the National Institute of Child Health and Human Development in Bethesda, Md

Published
07 March 2014
From
MedPage Today
HIV increases fracture risk, say Danes

HIV infection increases the risk of fractures, Danish investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The case controlled study used data

Published
04 February 2014
By
Michael Carter
← First12345...8Next →

Filter by country